Organon & Co (OGN)
15.28
+0.39
(+2.62%)
USD |
NYSE |
Nov 22, 16:00
15.35
+0.07
(+0.46%)
Pre-Market: 20:00
Organon Cash from Operations (Quarterly): 141.00M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 141.00M |
| June 30, 2024 | 332.00M |
| March 31, 2024 | 76.00M |
| December 31, 2023 | 397.00M |
| September 30, 2023 | 261.00M |
| June 30, 2023 | 27.00M |
| March 31, 2023 | 114.00M |
| December 31, 2022 | 267.00M |
| September 30, 2022 | 317.00M |
| June 30, 2022 | 151.00M |
| Date | Value |
|---|---|
| March 31, 2022 | 123.00M |
| December 31, 2021 | 47.00M |
| September 30, 2021 | 368.00M |
| June 30, 2021 | 539.00M |
| March 31, 2021 | 1.504B |
| December 31, 2020 | 430.00M |
| September 30, 2020 | 288.00M |
| June 30, 2020 | 803.00M |
| March 31, 2020 | 666.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
27.00M
Minimum
Jun 2023
1.504B
Maximum
Mar 2021
360.58M
Average
288.00M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
| ResMed Inc | 325.54M |
| TG Therapeutics Inc | -12.20M |
| Sage Therapeutics Inc | -82.36M |
| Applied Therapeutics Inc | -23.33M |
| Vor Biopharma Inc | -23.28M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -75.00M |
| Cash from Financing (Quarterly) | -78.00M |
| Free Cash Flow | 646.00M |
| Free Cash Flow Per Share (Quarterly) | 0.2502 |
| Free Cash Flow to Equity (Quarterly) | -28.00M |
| Free Cash Flow to Firm (Quarterly) | 283.52M |
| Free Cash Flow Yield | 16.37% |